Inhaled Version of Antiviral Drug to Begin Human Testing
Clinical trials on an inhaled type of the antiviral treatment remdesivir will start on patients with COVID-19 beginning in August. Phase 1 trials on healthy volunteers will begin the week of June 22. Made by Gilead Sciences Inc, remdesivir…